Clinical trial

Safety Study of Interferon Beta 1a to for Acute Stroke

NCT00097318 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed

Key facts

NCT number NCT00097318
Title Safety Study of Interferon Beta 1a to for Acute Stroke
Official title Recombinant Human Interferon Beta-1a in Acute Ischemic Stroke: A Dose Escalation and Safety Study
Lead sponsor National Institute of Neurological Disorders and Stroke (NINDS), NIH
Status Completed
Phase Phase 1
Study type Interventional
Conditions Cerebrovascular Accident
Intervention type Drug
Interventions Interferon beta-1a
Enrollment 60
Start date Nov 17, 2004
Completion Apr 8, 2011
First posted Nov 22, 2004
Last update posted Jul 2, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies